7ZOK

A novel molecular switch controls assembly of bacterial focal adhesions in response to changes in surface structure.

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-15N NOESY	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
2	3D 1H-13C NOESY	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
3	2D 1H-1H NOESY	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
4	3D 1H-15N TOCSY	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
5	3D HCCH-TOCSY	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
6	3D 1H-13C HSQC aliphatic	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
7	3D 1H-13C NOESY aromatic	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
8	3D CBCA(CO)NH	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
9	3D HNCACB	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
10	3D HNCO	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
11	2D 1H-13C HSQC	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600
12	3D HNCA	0.45 mM [U-100% 13C; U-100% 15N] ZnR	90% H2O/10% D2O	10 mM	7	1 atm	303	Bruker AVANCE II 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE II	600

NMR Refinement
Method	Details	Software
simulated annealing		Amber

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	chemical shift assignment	CcpNmr Analysis		CCPN
3	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
4	refinement	Amber		Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.